Project Aims to Scale-Up Commercial Platform
for DNA Marking of Bearings
Applied DNA Sciences, Inc. ("Applied DNA," "the company,"
NASDAQ:APDN), is commencing production-scale DNA marking of
bearings with a global leader in the manufacture of bearings, at a
domestic manufacturing facility. The work will be performed under
the newly awarded Rapid Innovation Fund (RIF) contract issued by
the Office of the Secretary of Defense (OSD) on behalf of the
Defense Logistics Agency (DLA), and reflects Applied DNA’s efforts
to commercialize processes and methodologies developed for the
Department of Defense and apply them to commercial OEMs.
This production-scale project is a follow-up to successful pilot
conducted under Applied DNA’s prior OSD RIF contract, completed in
August of 2016. Through collaborative efforts led by the R&D
team of the US-based bearing manufacturer, along with DLA
Aviation’s subject matter experts from Richmond, VA, Applied DNA
scientists tested and qualified blending SigNature® DNA into
preservative lubricants used in the manufacturing of bearings. This
innovative solution for DNA marking of bearings should provide
little to no impact on the manufacturing process, which will be
confirmed in the initial phase of production testing.
The immediate goal of the project is to assist in securing the
Department of Defense supply chain, but Applied DNA believes the
platform can easily be leveraged by commercial stakeholders,
globally. Preservative lubricants are used in wide-ranging
industrial applications, tool manufacturing, pneumatic equipment
and small arms.
Bob MacDowell, Applied DNA Director, Government and Military
Program Sales commented, “Our DNA-based solutions provide
significant value in many different applications, allowing
traceability to source along a supply chain. The most effective
deployment of the DNA is at the point of manufacture, which creates
the broadest platform possible and enables all stakeholders to
benefit from the solution.”
“Agriculture, industrial equipment and the automotive industry
are all focus markets for the bearings industry at large, which
align well with Applied DNA’s roadmap for current markets to
penetrate. We are hopeful the success of this production project,
will secure DLA’s bearing supply chain, and lead to larger
opportunities in additional markets where both the bearing
manufacturer and their customers can mutually benefit,” stated Dr.
James Hayward, president and CEO of Applied DNA.
The aerospace bearings market was valued at $7.88 billion in
2016 and is projected to reach $11.19 billion by 20221. The overall
global market for bearings, currently valued at greater than $84
billion, is projected to grow by 67 percent to $140 billion by
20222.
1.
http://www.marketsandmarkets.com/Market-Reports/aerospace-bearing-market-191707655.html
2. https://www.alliedmarketresearch.com/bearings-market
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT™” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is
at the heart of a family of uncopyable, security and authentication
solutions such as SigNature® T and fiberTyping®, targeted toward
textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and
loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the symbol
APDN, and its warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017, and May 11, 2017 which are available at
www.sec.gov. APDN undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170810005129/en/
Investors:LHA Investor RelationsSanjay Hurry,
212-838-3777shurry@lhai.comorMedia:Dian Griesel Int’lSusan
Forman, 212-825-3210sforman@dgicomm.comorProgram:Applied DNA
SciencesBob MacDowell,
631-240-8823bob.macdowell@adnas.comweb:
www.adnas.comtwitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024